Mycoder

Mycoder may be available in the countries listed below.

Ingredient matches for Mycoder

Fluconazole

Fluconazole is reported as an ingredient of Mycoder in the following countries:

• Bangladesh

International Drug Name Search

Isotard

Isotard may be available in the countries listed below.

UK matches:

• Isotard 25, 40, 50 and 60 mg XL Tablets
• Isotard XL (SPC)

Ingredient matches for Isotard

Isosorbide Dinitrate

Isosorbide Dinitrate is reported as an ingredient of Isotard in the following countries:

• Israel

Isosorbide Mononitrate

Isosorbide Mononitrate is reported as an ingredient of Isotard in the following countries:

• United Kingdom

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Brilinta

Pronunciation: tye-KA-grel-or
Generic Name: Ticagrelor
Brand Name: Brilinta

Brilinta can cause serious and sometimes fatal bleeding problems. Do not use Brilinta if you have an active bleeding problem or a history of bleeding in the brain.

Tell your doctor if you have recently had surgery or if you are scheduled to have surgery. You may need to stop taking Brilinta before you have surgery. Discuss any questions or concerns with your doctor.

Brilinta should be taken along with aspirin. Do not exceed the dose of aspirin recommended by your doctor while you are taking Brilinta. Taking doses of aspirin that are higher than the dose recommended while you are taking Brilinta may decrease Brilinta's effectiveness.

Brilinta is used for:

Reducing the risk of stroke, heart attack, or death in certain patients who have had a heart attack or who have angina (chest pain). It should be used along with aspirin as directed by your doctor. It also may be used for other conditions as determined by your doctor.

Brilinta is a platelet aggregation inhibitor. It works by slowing or stopping platelets from sticking to blood vessel walls or injured tissues.

Do NOT use Brilinta if:

• you are allergic to any ingredient in Brilinta


• you have an active bleeding problem (eg, bleeding stomach ulcer, bleeding in the brain) or a history of bleeding in the brain


• you have severe liver problems


• you are taking certain azole antifungals (eg, itraconazole, ketoconazole, voriconazole), carbamazepine, dexamethasone, certain macrolide antibiotics (eg, clarithromycin), nefazodone, phenobarbital, phenytoin, certain protease inhibitors (eg, atazanavir, ritonavir), rifampin, or telithromycin

Contact your doctor or health care provider right away if any of these apply to you.

Before using Brilinta:

Some medical conditions may interact with Brilinta. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have liver or kidney problems, lung or breathing problems (eg, asthma, chronic obstructive pulmonary disease [COPD]), recent stomach or bowel bleeding, or a history of ulcers or bowel polyps


• if you have had a recent injury or surgery, including dental surgery; if you will be having surgery or a dental procedure; or if you are on dialysis


• if you have certain irregular heartbeat problems (eg, sick sinus syndrome, second- or third-degree heart block), or you have fainting caused by slow heartbeat and you do not have a permanent pacemaker


• if you have a history of bleeding or clotting problems, stroke, gouty arthritis, or high blood uric acid levels


• if you have received medicine to dissolve a blood clot (eg, alteplase) within 24 hours of taking Brilinta


• if you take another medicine to prevent or treat blood clots

Some MEDICINES MAY INTERACT with Brilinta. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Anticoagulants (eg, heparin, warfarin), direct thrombin inhibitors (eg, dabigatran, desirudin), nonsteroidal anti-inflammatory drugs (NSAIDs) (eg, celecoxib, ibuprofen), rivaroxaban, or salicylates (eg, aspirin) because the risk of bleeding may be increased


• Azole antifungals (eg, fluconazole, ketoconazole, voriconazole), macrolide antibiotics (eg, clarithromycin, erythromycin), nefazodone, protease inhibitors (eg, amprenavir, atazanavir, ritonavir), or telithromycin because they may increase the risk of Brilinta's side effects


• Carbamazepine, dexamethasone, efavirenz, hydantoins (eg, phenytoin), phenobarbital, primidone, rifamycins (eg, rifampin), or St. John's wort because they may decrease Brilinta's effectiveness


• Digoxin, lovastatin, or simvastatin because the risk of their side effects may be increased by Brilinta

This may not be a complete list of all interactions that may occur. Ask your health care provider if Brilinta may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Brilinta:

Use Brilinta as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Brilinta comes with an extra patient information sheet called a Medication Guide. Read it carefully. Read it again each time you get Brilinta refilled.


• Take Brilinta by mouth with or without food.


• Take Brilinta on a regular schedule to get the most benefit from it.


• If you miss a dose of Brilinta, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Brilinta.

Important safety information:

• Brilinta may cause dizziness. This effect may be worse if you take it with alcohol or certain medicines. Use Brilinta with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.


• Do not stop taking Brilinta without checking with your doctor. This may increase the risk of certain heart problems. If you need to stop taking Brilinta, follow your doctor's directions carefully.


• Do not exceed the dose of aspirin recommended by your doctor while you are taking Brilinta. Before you start any new medicine, check the label to see if it has aspirin in it too. If it does or if you are not sure, check with your doctor or pharmacist.


• Brilinta reduces the action of the clot-forming cells (platelets) in your blood. Avoid activities that may cause bruising or injury. Tell your doctor if you have unusual bruising or bleeding. Tell your doctor if you have dark, tarry, or bloody stools.


• Tell your doctor or dentist that you take Brilinta before you receive any medical or dental care, emergency care, or surgery. You may need to stop Brilinta before you have certain types of surgery.


• Use Brilinta with caution in the ELDERLY; they may be more sensitive to its effects, especially bleeding problems.


• Brilinta should be used with extreme caution in CHILDREN; safety and effectiveness in children have not been confirmed.


• PREGNANCY and BREAST-FEEDING: Avoid becoming pregnant while you are taking Brilinta. If you think you may be pregnant, contact your doctor. You will need to discuss the benefits and risks of taking Brilinta while you are pregnant. It is not known if Brilinta is found in breast milk. Do not breast-feed while taking Brilinta.

Possible side effects of Brilinta:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Back pain; cough; diarrhea; dizziness; headache; nausea; minor bleeding; tiredness.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); bleeding in the eye; bloody or black, tarry stools; chest pain; coughing up blood; dark or bloody urine; fainting; fast, slow, or irregular heartbeat; light-headedness; purple skin patches; severe or persistent headache or dizziness; shortness of breath; symptoms of stroke (eg, sudden numbness or weakness of an arm, leg, or the face; one-sided weakness; sudden confusion, trouble speaking, or trouble understanding others; loss of balance, coordination, or trouble walking; sudden severe headache or dizziness with no known cause); unusual bruising; unusual, prolonged, or severe bleeding (eg, excessive bleeding from cuts, increased menstrual bleeding, nosebleeds, unexplained vaginal bleeding, unusual bleeding from the gums when brushing); vomiting blood or vomit that looks like coffee grounds.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Brilinta side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include irregular heartbeat; severe diarrhea, nausea, or vomiting; unusual bruising or bleeding.

Proper storage of Brilinta:

Store Brilinta at room temperature, between 59 and 86 degrees F (15 and 30 degrees C) in its original container. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Brilinta out of the reach of children and away from pets.

General information:

• If you have any questions about Brilinta, please talk with your doctor, pharmacist, or other health care provider.


• Brilinta is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Brilinta. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Brilinta resources

• Brilinta Side Effects (in more detail)
• Brilinta Use in Pregnancy & Breastfeeding
• Brilinta Drug Interactions
• Brilinta Support Group
• 0 Reviews for Brilinta - Add your own review/rating

• Brilinta Consumer Overview


• Brilinta Advanced Consumer (Micromedex) - Includes Dosage Information


• Ticagrelor Professional Patient Advice (Wolters Kluwer)

Compare Brilinta with other medications

• Acute Coronary Syndrome

Clomipramin-CT

Clomipramin-CT may be available in the countries listed below.

Ingredient matches for Clomipramin-CT

Clomipramine

Clomipramine hydrochloride (a derivative of Clomipramine) is reported as an ingredient of Clomipramin-CT in the following countries:

• Germany

International Drug Name Search

Ufonitren

Ufonitren may be available in the countries listed below.

Ingredient matches for Ufonitren

Omeprazole

Omeprazole is reported as an ingredient of Ufonitren in the following countries:

• Ethiopia


• Greece


• Latvia

International Drug Name Search

Quedox

Quedox may be available in the countries listed below.

Ingredient matches for Quedox

Clarithromycin

Clarithromycin is reported as an ingredient of Quedox in the following countries:

• Mexico

International Drug Name Search

Procardia XL

See also: Generic Procardia

Procardia XL is a brand name of nifedipine, approved by the FDA in the following formulation(s):

PROCARDIA XL (nifedipine - tablet, extended release; oral)

• 
  Manufacturer: PFIZER
  
  Approval date: September 6, 1989
  
  Strength(s): 30MG ^[AB2], 60MG ^[AB2], 90MG ^[RLD][AB2]

Has a generic version of Procardia XL been approved?

Yes. The following products are equivalent to Procardia XL:

nifedipine tablet, extended release; oral

• 
  Manufacturer: MATRIX LABS LTD
  
  Approval date: September 13, 2010
  
  Strength(s): 30MG ^[AB2], 60MG ^[AB2], 90MG ^[AB2]


• 
  Manufacturer: MYLAN
  
  Approval date: June 21, 2010
  
  Strength(s): 30MG ^[AB2], 60MG ^[AB2], 90MG ^[AB2]


• 
  Manufacturer: OSMOTICA PHARM
  
  Approval date: November 21, 2005
  
  Strength(s): 30MG ^[AB2], 60MG ^[AB2]


• 
  Manufacturer: OSMOTICA PHARM
  
  Approval date: October 3, 2007
  
  Strength(s): 90MG ^[AB2]


• 
  Manufacturer: VALEANT INTL
  
  Approval date: September 27, 2000
  
  Strength(s): 60MG ^[AB2]


• 
  Manufacturer: VALEANT INTL
  
  Approval date: February 6, 2001
  
  Strength(s): 30MG ^[AB2]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Procardia XL. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Procardia XL.

See also...

• Procardia XL Sustained-Release Tablets Consumer Information (Wolters Kluwer)
• Procardia XL Consumer Information (Cerner Multum)
• Procardia XL Advanced Consumer Information (Micromedex)
• Nifedipine Consumer Information (Drugs.com)
• Nifedipine Consumer Information (Wolters Kluwer)
• Nifedipine Sustained-Release Tablets Consumer Information (Wolters Kluwer)
• Nifedipine Consumer Information (Cerner Multum)
• Nifedipine Advanced Consumer Information (Micromedex)
• Nifedipine AHFS DI Monographs (ASHP)

Farmicetina

Farmicetina may be available in the countries listed below.

Ingredient matches for Farmicetina

Chloramphenicol

Chloramphenicol is reported as an ingredient of Farmicetina in the following countries:

• Argentina

International Drug Name Search

Calcitonine

Calcitonine may be available in the countries listed below.

Ingredient matches for Calcitonine

Calcitonin

Calcitonine (DCF) is known as Calcitonin in the US.

International Drug Name Search

Glossary

DCF	Dénomination Commune Française

Click for further information on drug naming conventions and International Nonproprietary Names.

Spektramox

Spektramox may be available in the countries listed below.

Ingredient matches for Spektramox

Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Spektramox in the following countries:

• Denmark


• Sweden

Clavulanate

Clavulanic Acid potassium (a derivative of Clavulanic Acid) is reported as an ingredient of Spektramox in the following countries:

• Denmark


• Sweden

International Drug Name Search

Etibi

Etibi may be available in the countries listed below.

Ingredient matches for Etibi

Ethambutol

Ethambutol dihydrochloride (a derivative of Ethambutol) is reported as an ingredient of Etibi in the following countries:

• Austria


• Canada

International Drug Name Search

OQ-Miot

OQ-Miot may be available in the countries listed below.

Ingredient matches for OQ-Miot

Acetylcholine

Acetylcholine Chloride is reported as an ingredient of OQ-Miot in the following countries:

• Colombia

International Drug Name Search